Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.
Sherlock
Mark
M
Toogood
Andy A
AA
Steeds
Richard
R
D000077465:Cabergoline; D018491:Dopamine Agonists / Q000009:adverse effects*; D004452:Echocardiography; D004873:Ergolines / Q000009:adverse effects; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006351:Heart Valves / Q000187:drug effects; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000009:adverse effects; D014262:Tricuspid Valve Insufficiency / Q000139:chemically induced
D018491:Dopamine Agonists; D004873:Ergolines; D010479:Pergolide; D000077465:Cabergoline